comparemela.com

Latest Breaking News On - Roel bulthuis - Page 1 : comparemela.com

Form 20-F Achilles Therapeutics For: Dec 31

Form 20-F Achilles Therapeutics For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Israel
Russia
Chiron
Zabaykal-skiy-kray
Odense
Syddanmark
Denmark
Liechtenstein
Canada
Norway
Delaware
United-states

Syncona : Appoints Roel Bulthuis as Managing Partner

Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life science, today announces the appointment of Roel Bulthuis as Managing Partner and Head. | April 5, 2023

Finland
Netherlands
Helsinki
Eteläuomen-läi
Amsterdam
Noord-holland
Chris-hollowood
Roel-bulthuis
Merck-serono
Msc-in-biopharmaceutical-sciences
Syncona-investment-management
Helsinki-school-of-economics

Optimum Strategic Communications Hosts 14th Annual Healthcare Investor Conference

/PRNewswire/ Optimum Strategic Communications (Optimum), the international strategic healthcare communications consultancy, will be hosting its 14th Annual.

New-york
United-states
Zurich
Züsz
Switzerland
Stockholm
Sweden
London
City-of
United-kingdom
Amsterdam
Noord-holland

NMD Pharma Raises €35 Million in a new Financing

NMD Pharma Raises €35 Million in a new Financing - New investor Jeito Capital joins current NMD Pharma investors - Proceeds will be used to progress lead clinical programs

Japan
United-states
Paris
France-general
France
Denmark
Danish
Kostenloser-wertpapierhandel
Sabine-dandiguian
Sabine-dandiguianto
Roel-bulthuis
Novo-nordisk

NMD Pharma Raises €35 Million in a new Financing

NMD Pharma Raises €35 Million in a new Financing - New investor Jeito Capital joins current NMD Pharma investors - Proceeds will be used to progress lead.

Japan
United-states
Denmark
Sabine-dandiguian
Sabine-dandiguianto
Roel-bulthuis
Thomas-holm-pedersen
European-union
Lundbeck-foundation
Roche-venture-fund
Novo-holdings
Aarhus-university

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.